Nanoparticles Evading the Reticuloendothelial System: Role of the Supported Bilayer

Overview

Journal Biochim Biophys Acta

Specialties Biochemistry
Biophysics

Date 2009 Jul 15

PMID 19595666

Citations 142

Authors

Shyh-Dar Li

Leaf Huang

Affiliations

Soon will be listed here.

Abstract

We have previously shown that the PEGylated LPD (liposome-polycation-DNA) nanoparticles were highly efficient in delivering siRNA to the tumor with low liver uptake. Its mechanism of evading the reticuloendothelial system (RES) is reported here. In LPD, nucleic acids were condensed with protamine into a compact core, which was then coated by two cationic lipid bilayers with the inner bilayer stabilized by charge-charge interaction (also called the supported bilayer). Finally, a detergent-like molecule, polyethylene glycol (PEG)-phospholipid is post-inserted into the lipid bilayer to modify the surface of LPD. The dynamic light scattering (DLS) data showed that LPD had improved stability compared to cationic liposomes after incubation with a high concentration of DSPE-PEG(2000), which is known to disrupt the bilayer. LPD prepared with a multivalent cationic lipid, DSGLA, had enhanced stability compared to those containing DOTAP, a monovalent cationic lipid, suggesting that stronger charge-charge interaction in the supported bilayer contributed to a higher stability. Distinct nanoparticle structure was found in the PEGylated LPD by transmission electron microscopy, while the cationic liposomes were transformed into tubular micelles. Size exclusion chromatography data showed that approximately 60% of the total cationic lipids, which were located in the outer bilayer of LPD, were stripped off during the PEGylation; and about 20% of the input DSPE-PEG(2000) was incorporated into the inner bilayer with about 10.6 mol% of DSPE-PEG(2000) presented on the particle surface. This led to complete charge shielding, low liver sinusoidal uptake, and 32.5% injected dose delivered to the NCI-H460 tumor in a xenograft model.

Citing Articles

Innovative Approaches to Enhancing the Biomedical Properties of Liposomes.

Dejeu I, Vicas L, Marian E, Ganea M, Frent O, Maghiar P Pharmaceutics. 2025; 16(12.

PMID: 39771504 PMC: 11728823. DOI: 10.3390/pharmaceutics16121525.

pH-Responsive Polyethylene Glycol Engagers for Enhanced Brain Delivery of PEGylated Nanomedicine to Treat Glioblastoma.

Meng J, Dong Z, Chen Y, Lin M, Liu Y, Roffler S ACS Nano. 2025; 19(1):307-321.

PMID: 39749925 PMC: 11752499. DOI: 10.1021/acsnano.4c05906.

Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery.

Ho K, Liu Y, Liao T, Liu E, Cheng T Int J Nanomedicine. 2024; 19:10045-10064.

PMID: 39371476 PMC: 11453133. DOI: 10.2147/IJN.S479270.

RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens.

Kola N, Patel D, Thakur A Methods Mol Biol. 2024; 2813:321-370.

PMID: 38888787 DOI: 10.1007/978-1-0716-3890-3_21.

New insights into targeted therapy of glioblastoma using smart nanoparticles.

Ghaznavi H, Afzalipour R, Khoei S, Sargazi S, Shirvalilou S, Sheervalilou R Cancer Cell Int. 2024; 24(1):160.

PMID: 38715021 PMC: 11077767. DOI: 10.1186/s12935-024-03331-3.

References

Klibanov A, Maruyama K, Torchilin V, Huang L . Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990; 268(1):235-7. DOI: 10.1016/0014-5793(90)81016-h. View

Li S, Huang L . In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 1998; 4(9):891-900. DOI: 10.1038/sj.gt.3300482. View

Tan Y, Whitmore M, Li S, Frederik P, Huang L . LPD nanoparticles--novel nonviral vector for efficient gene delivery. Methods Mol Med. 2002; 69:73-81. DOI: 10.1385/1-59259-141-8:073. View

Brannon-Peppas L, Blanchette J . Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004; 56(11):1649-59. DOI: 10.1016/j.addr.2004.02.014. View

Owens 3rd D, Peppas N . Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2005; 307(1):93-102. DOI: 10.1016/j.ijpharm.2005.10.010. View

Woodle M, Lasic D . Sterically stabilized liposomes. Biochim Biophys Acta. 1992; 1113(2):171-99. DOI: 10.1016/0304-4157(92)90038-c. View

Li S, Huang L . Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Mol Pharm. 2006; 3(5):579-88. DOI: 10.1021/mp060039w. View

Silvander M, Johnsson M, Edwards K . Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum. Chem Phys Lipids. 1999; 97(1):15-26. DOI: 10.1016/s0009-3084(98)00088-7. View

Li S, Chen Y, Hackett M, Huang L . Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther. 2007; 16(1):163-9. PMC: 2739987. DOI: 10.1038/sj.mt.6300323. View

10.

Uster P, Allen T, Daniel B, Mendez C, NEWMAN M, Zhu G . Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett. 1996; 386(2-3):243-6. DOI: 10.1016/0014-5793(96)00452-8. View

11.

Garbuzenko O, Barenholz Y, Priev A . Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem Phys Lipids. 2005; 135(2):117-29. DOI: 10.1016/j.chemphyslip.2005.02.003. View

12.

Monsky W, Fukumura D, Gohongi T, Ancukiewcz M, Weich H, Torchilin V . Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 1999; 59(16):4129-35. View

13.

Yan X, Scherphof G, Kamps J . Liposome opsonization. J Liposome Res. 2005; 15(1-2):109-39. DOI: 10.1081/lpr-64971. View

14.

Chen Y, Sen J, Reddy Bathula S, Yang Q, Fittipaldi R, Huang L . Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells. Mol Pharm. 2009; 6(3):696-705. PMC: 2763490. DOI: 10.1021/mp800136v. View

15.

Nicholas A, Scott M, Kennedy N, Jones M . Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. Biochim Biophys Acta. 2000; 1463(1):167-78. DOI: 10.1016/s0005-2736(99)00192-3. View

16.

Vangasseri D, Han S, Huang L . Lipid-protamine-DNA-mediated antigen delivery. Curr Drug Deliv. 2005; 2(4):401-6. DOI: 10.2174/156720105774370168. View

17.

Li S, Chono S, Huang L . Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. J Control Release. 2007; 126(1):77-84. PMC: 2692667. DOI: 10.1016/j.jconrel.2007.11.002. View

18.

Kenworthy A, Hristova K, Needham D, McIntosh T . Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). Biophys J. 1995; 68(5):1921-36. PMC: 1282095. DOI: 10.1016/S0006-3495(95)80369-3. View

19.

Li S, Chono S, Huang L . Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA. Mol Ther. 2008; 16(5):942-6. PMC: 2778045. DOI: 10.1038/mt.2008.51. View

20.

Dos Santos N, Allen C, Doppen A, Anantha M, Cox K, Gallagher R . Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta. 2007; 1768(6):1367-77. DOI: 10.1016/j.bbamem.2006.12.013. View